Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

STEMI Clinical Trials

5 recruiting trials for STEMI. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
5
Total Trials
5
Recruiting Now
0
Phase 3 Trials
4
Sponsors

Recruiting Trials

RECRUITINGPhase 2NCT06342141

Empagliflozin for No-reflow Phenomenon in PCI for STEMI

Myocardial infarction remains, in our current era, a leading cause of morbidity and mortality both domestically and globally. A significant contributor to this issue is...

Sponsor: Instituto Nacional de Cardiologia Ignacio ChavezEnrolling: 1621 location
RECRUITINGNCT07055152

Retinal OCTA for Microvascular Dysfunction Evaluation and Outcome Prediction in MINOCA Patients

The aim of this study is to evaluate microvascular dysfunction through OCTA in MINOCA patients. In order to better understand the condition, OCTA will also be performed in two...

Sponsor: University of PisaEnrolling: 901 location
RECRUITINGNCT02778724

France PCI Registry : National Observatory of Interventional Cardiology

Rigorous clinical practice assessment is a key factor to improve patient's care and prognosis in interventional cardiology (IC). A multicentric IC observational study (CRAC),...

Sponsor: Club Régional des Angioplasticiens de la région CentreEnrolling: 4000015 locations
RECRUITINGNCT07041840

ReModeling in ST-elevation myocARrdial Infarction: a Comparison of Left VEntricuLar Functions in Long-term Follow-up...

Patients diagnosed with STEMI who underwent pPCI were included in this study. The investigators collected comprehensive data on each patient's status, including laboratory...

Sponsor: University of PisaEnrolling: 801 location
RECRUITINGNCT06966674

No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track

This study aims to assess the no-reflow in patients with STEMI after intracoronary glycoprotein IIb/IIIa inhibitors after opening of track in thrombus.

Sponsor: Kafrelsheikh UniversityEnrolling: 601 location